601567 三星医疗
2023/09 - 九个月
人民幣(K¥)
与去年同期
比较
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
2019/12
人民幣(K¥)
营业总收入8,337,76020.81%9,098,2037,022,9027,092,7096,805,309
减:营业总成本6,923,06014.62%8,045,1076,520,1786,279,0156,070,956
    其中:营业成本5,534,69611.98%6,470,4775,241,3575,054,5664,835,331
               财务费用(18,668)-307.26%(14,853)88,30294,54122,250
               资产减值损失3,982-9.91%(11,539)(13,066)(15,861)(13,442)
公允价值变动收益88,886-178.95%(107,481)103,69765,383(102,608)
投资收益181,2781,445.01%84,951204,334337,618569,990
    其中:对联营企业和合营企业的投资收益137,4208.57%189,892134,226118,764255,748
营业利润1,761,696111.23%1,152,349851,2271,192,5281,206,119
利润总额1,759,729106.90%1,152,047846,8131,188,5331,199,940
减:所得税费用260,78795.39%187,042139,204227,654184,792
净利润1,498,942109.04%965,005707,609960,8791,015,148
减:非控股权益9,614-37.76%16,88917,5674,75910,770
股东净利润1,489,328112.27%948,116690,043956,1201,004,379

市场价值指针
每股收益 (元) *1.050110.00%0.6700.5000.6900.720
每股派息 (元) *----0.3500.3200.3500.210
每股净资产 (元) *7.51513.95%6.7296.3336.2175.799
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容